Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ELDN Hot Sheet
Join SI Premium – FREE
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q4 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Seaport Global Securities Upgrades Asbury Automotive Group (ABG) to Buy
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
